Bausch Health Announces Changes to its Board of Directors
Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) announced the retirement of board members Richard De Schutter and Dr. Argeris Karabelas, effective at the upcoming 2023 annual shareholder meeting. With their departure, the board size will reduce to 10 members. Chairperson John A. Paulson expressed gratitude for their contributions. The board's committee structure has been refreshed, details of which are available on the company's website. Bausch Health continues its mission to enhance lives through healthcare products across various sectors, including gastroenterology and eye health.
- Board refreshment may bring new perspectives.
- Continued commitment to improving global health.
- Loss of experienced board members could impact strategic continuity.
LAVAL, QC / ACCESSWIRE / March 1, 2023 / Bausch Health Companies Inc. (TSX:BHC)(NYSE:BHC) today announced that Richard De Schutter and Dr. Argeris Karabelas are retiring from the Company's Board of Directors, effective as of the upcoming 2023 annual meeting of shareholders of the Company. Following the retirements of Mr. De Schutter and Dr. Karabelas, the size of the Board will be reduced to 10 directors.
"Dick and Jerry have been valued members of our Board and their service to the Company has been greatly appreciated. The Company and entire Board are grateful for their contributions," said John A. Paulson, Chairperson of the Bausch Health Board.
As result of the retirements of Mr. De Schutter and Dr. Karabelas, the Board has refreshed certain Board Committees. The current Board Committee structure is available on the Company's website: https://ir.bauschhealth.com/corporate-governance.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX:BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
Forward-Looking Statements
This news release may contain forward-looking statements about the future performance of Bausch Health which may generally be identified by the use of the words "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual report on Form 10-K and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference.
| Investor Contact: | Media Contacts: |
| Mark Maico | Kevin Wiggins |
| ir@bauschhealth.com | corporate.communications@bauschhealth.com |
| (514) 856-3855 | (908) 541-3785 |
| (877) 281-6642 (toll free) |
SOURCE: Bausch Health Companies Inc
View source version on accesswire.com:
https://www.accesswire.com/741345/Bausch-Health-Announces-Changes-to-its-Board-of-Directors
FAQ
What recent changes occurred in Bausch Health's Board of Directors?
Who expressed gratitude for the contributions of retiring board members at Bausch Health?
How will the board structure change at Bausch Health after the retirements?
What is the significance of the board changes for Bausch Health's future?
